Microbot Medical Inc (NASDAQ:MBOT)’s share price traded up 0% on Wednesday . The company traded as high as $1.13 and last traded at $1.09. 2,569,223 shares were traded during mid-day trading, an increase of 59% from the average session volume of 1,616,912 shares. The stock had previously closed at $1.09.
In other Microbot Medical news, Director Moshe Shoham sold 33,700 shares of the company’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $1.50, for a total value of $50,550.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Yoseph Bornstein sold 42,132 shares of the company’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $1.01, for a total value of $42,553.32. The disclosure for this sale can be found here. Insiders sold a total of 421,690 shares of company stock worth $489,344 over the last 90 days. Corporate insiders own 31.83% of the company’s stock.
An institutional investor recently bought a new position in Microbot Medical stock. Sabby Management LLC acquired a new stake in shares of Microbot Medical Inc (NASDAQ:MBOT) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned about 2.92% of Microbot Medical at the end of the most recent quarter. Institutional investors and hedge funds own 4.66% of the company’s stock.
Microbot Medical Company Profile
Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.